10x Genomics Reports First Quarter 2023 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
10x Genomics (TXG) Misses Q1 EPS by 10c; Offers FY23 Revenue Guidance
May 3, 2023 4:37 PM EDT10x Genomics (NASDAQ: TXG) reported Q1 EPS of ($0.44), $0.10 worse than the analyst estimate of ($0.34). Revenue for the quarter came in at $134.3 million versus the consensus estimate of $129.24 million.
GUIDANCE:
10x Genomics sees FY2023 revenue of $590-610 million, versus the consensus... More



